Status: Recruiting
Clinical Efficacy of Transarterial Infusion Chemotherapy for Unresectable Colorectal Cancer
This is a prospective, multicenter, randomized, open-label clinical trial. It aims to investigate whether intensive transarterial infusion chemotherapy (TAIC) followed by sequential intravenous chemotherapy (IVC) is clinically more effective than IVC alone in the treatment of unresectable colorectal cancer (uCRC).
Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Quanda LiuUpdated: Aug 14, 2026Locations: 1
Eligibility criteria
Age ≥ 18 years old; [+18]